MYAM
ROIV icon

Meiji Yasuda Asset Management’s Roivant Sciences ROIV Stock Holding History

Meiji Yasuda Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Hold
10,402
– – 0.02% 421
2026
Q1 		$288K Buy
10,402
+348
+3% +$8.94K 0.01% 445
2025
Q4 		$218K Sell
10,054
-137
-1% -$2.7K 0.01% 523
2025
Q3 		$154K Hold
10,191
– – 0.01% 540
2025
Q2 		$115K Hold
10,191
– – 0.01% 540
2025
Q1 		$103K Sell
10,191
-290
-3% -$3.14K ﹤0.01% 640
2024
Q4 		$124K Sell
10,481
-255
-2% -$3.02K ﹤0.01% 673
2024
Q3 		$124K Buy
+10,736
New +$122K ﹤0.01% 670

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Meiji Yasuda Asset Management's ROIV Position: Q2 2026 in Review

Meiji Yasuda Asset Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 10,402 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #421.

Meiji Yasuda Asset Management first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Meiji Yasuda Asset Management held 10,402 shares of Roivant Sciences worth $368K as of Q2 2026.
  • Meiji Yasuda Asset Management left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.02% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #421 holding.
  • Meiji Yasuda Asset Management first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.